Cerenome (CNSY) Total Debt Growth (3y) (2013 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 19.52% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 4.76% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -22.30% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -49.10% |
| Dec 31, 2025 | -48.19% |
| Dec 31, 2024 | -20.75% |
| Sep 30, 2024 | -21.29% |
| Jun 30, 2024 | -20.77% |
| Mar 31, 2024 | -17.89% |
| Dec 31, 2023 | -14.38% |
| Sep 30, 2023 | -11.06% |
| Jun 30, 2023 | -7.89% |
| Mar 31, 2023 | -23.24% |
| Dec 31, 2022 | -21.29% |
| Sep 30, 2022 | -19.45% |
| Jun 30, 2022 | -17.70% |
| Mar 31, 2022 | -23.93% |
| Dec 31, 2021 | -22.49% |
| Sep 30, 2021 | -21.59% |
| Jun 30, 2021 | -21.79% |
| Mar 31, 2021 | -22.12% |
| Dec 31, 2020 | -22.53% |
| Sep 30, 2020 | -22.92% |